Healthy volunteers (n = 20) | HD patients (n = 60) | P value | HCV (+) patients (n = 30) | HCV (−) patients (n = 30) | P value | |
---|---|---|---|---|---|---|
Inflammatory parameters | ||||||
hs-CRP (mg/L) median (25-75%) | 1.83 (0.68-2.79) | 8.35 (3.52-16.22) | 0.005 | 12.20 (5.07-21.42) | 5.45 (3.25-1.57) | 0.181 |
TNF-alpha (pg/mL) | 6.4 ± 4.6 | 68.0 ± 104.1 | 0.026 | 76.1 ± 61.0 | 61.0 ± 29.6 | 0.593 |
IL-6 (pg/mL) | 3.5 ± 4.2 | 12.8 ± 10.1 | 0.021 | 9.1 ± 7.7 | 15.8 ± 10.9 | 0.016 |
Iron parameters | ||||||
Iron (μg/dL) median (25-75%) | 78 (60–118) | 71 (57–98) | 0.395 | 88 (66–130) | 64 (44–75) | <0.001 |
TIBC (μg/dL) | 289 ± 93 | 247 ± 50 | 0.156 | 229 ± 54 | 263 ± 41 | 0.012 |
TSAT (%) | 37.2 ± 24.2 | 35.1 ± 21.4 | 0.771 | 46.9 ± 24.1 | 24.7 ± 11.6 | <0.001 |
Ferritin (ng/mL) | 77 ± 76 | 705 ± 420 | <0.001 | 673 ± 503 | 699 ± 270 | 0.579 |
Prohepcidin (ng/mL) | 137 ± 20 | 142 ± 23 | 0.417 | 135 ± 25 | 148 ± 18 | 0.025 |
Total iron need (mg/year) median (25-75%) | 0 (0–200) | 150 (0–425) | 0.047 | |||
ESA resistance index | 0.03 (0.00-6.51) | 0.07 (0.00-6.58) | 0.039 |